Cookson Peirce & Co’s Pfizer PFE Stock Holding History

Cookson Peirce & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,891	Closed	-$221K	–	263
2024 Q2	$221K	Buy	+7,891	New	+$217K	0.01%	222
2023 Q1	–	Sell	-665,620	Closed	-$34.1M	–	248
2022 Q4	$34.1M	Buy	665,620 +1,736	+0.3%	+$83.2K	2.22%	14
2022 Q3	$29.1M	Buy	663,884 +7,108	+1%	+$345K	2.05%	11
2022 Q2	$34.4M	Buy	+656,776	New	+$33.5M	2.37%	6
2019 Q2	–	Sell	-1,051,853	Closed	-$42.4M	–	170
2019 Q1	$42.4M	Buy	1,051,853 +3,479	+0.3%	+$139K	3.58%	2
2018 Q4	$43.4M	Buy	1,048,374 +258,527	+33%	+$10.7M	4.19%	2
2018 Q3	$33M	Buy	+789,847	New	+$30.4M	2.65%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cookson Peirce & Co's PFE Position: Q3 2024 in Review

Cookson Peirce & Co sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,891 shares — an estimated $221K sold.

Cookson Peirce & Co first reported a position in PFE in Q3 2018 and held it in 7 quarters. The position peaked at $43.4M in Q4 2018. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Cookson Peirce & Co reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Cookson Peirce & Co sold 7,891 Pfizer shares in Q3 2024, an estimated $221K.
Cookson Peirce & Co first reported a position in Pfizer in Q3 2018 and held it in 7 quarters.
Cookson Peirce & Co's Pfizer position peaked at $43.4M in Q4 2018.
2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Cookson Peirce & Co's 13F filing for Q3 2024, filed 12 Nov 2024.